Skip to main content

Merck to seek emergency authorization for oral Covid treatment after ‘compelling results’ in trials

Merck and Ridgeback Biotherapeutics will seek emergency authorization for their drug, which they say could have “a profound impact in controlling the pandemic.”
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.